Acclaimed R&B singer D’Angelo passed away on October 14 at 51 years old after a personal fight with pancreatic malignancy.
“The shining star of our family has faded away for us in this life,” his relatives stated. “After a prolonged and brave struggle with the disease, we are heartbroken to declare that D’Angelo, recognized by his fans around the world as D’Angelo, has been taken from us.”
D’Angelo left an indelible mark on music with his innovative modern soul style and collaborations with high-profile artists.
He released his first record, “Brown Sugar,” in the mid-nineties to immediate acclaim. The album reached No. 4 on Billboard’s Top R&B Albums chart, went platinum later that year, and received multiple award nominations.
However, it was his sophomore release, “Voodoo,” in the year 2000 that propelled his music career into the stratosphere. The album debuted at the top spot on each of the R&B charts and the Billboard 200. He won two Grammys: Best R&B Album and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”
The music video for “Untitled (How Does It Feel)” solidified D’Angelo’s standing as a icon, albeit a reluctant one, in the cultural zeitgeist. The personal depiction showed the singer, notably stripped down to his midsection, singing directly into the camera.
D’Angelo stepped back from the spotlight after putting out Voodoo and publicly struggled with substance abuse. In 2005, he was part of a serious car crash that left him in critical condition.
Over ten years later, his last record, “Black Messiah” (2014), reaffirmed his lasting popularity with a further top chart entry on the R&B chart and a Grammy for Top R&B Record.
Once more, in his own enigmatic fashion, D’Angelo had limited public appearances in the subsequent period.
The singer was announced as a headliner for the 2025 Roots Picnic festival, but his appearance was called off, due to an “unforeseen medical delay.”
Even though details are sparse about D’Angelo’s health in the months before his death, he had apparently been in the hospital for months and in palliative care for two weeks.
D’Angelo’s demise is a clear example of the harmful impact of pancreatic malignancy, one of the most deadly and least preventable types of the illness, on a brilliant talent whose existence was cut short.
“We are grieved that he can only provide dear memories with his family, but we are eternally grateful for the heritage of extraordinarily moving music he leaves behind,” his family expressed.
Pancreatic malignancy impacts the digestive organ, a small organ that generates the hormone insulin and is vital in digestion, among additional roles. The position and dimensions of the pancreas in the human system make it more difficult to detect malignancy.
Although this cancer accounts for only approximately three percent of malignancy cases annually in the U.S., it is responsible for seven percent of cancer deaths.
Almost seventy thousand people will be found to have this condition and roughly 52,000 will die of the illness in 2025.
“This malignancy is one of the deadliest cancers, with an fast-growing mass and poor prognosis. We have few and ineffective therapies, and a narrow opportunity to make a significant difference on the well-being of people,” noted a medical oncologist.
Because this disease rarely causes initial signs, it’s often diagnosed only once the disease is late-stage. Although a patient has symptoms they are usually vague and may be mistaken for a number of common illnesses.
“Currently, there is no effective method to detect this malignancy in the early stages, except for listening to your body and consulting your physician if there are unfamiliar signs,” said a health expert.
Frequent indicators of this disease include:
At 51 years old, D’Angelo’s demise is an exception, as pancreatic cancer is most common in individuals in the sixty-five to seventy-five range. However, many cancers, including pancreatic cancer, have become more common in younger people.
“This disease identified before the age of 50 is deemed rare, yet alarmingly, clinicians are noticing a rising count of younger individuals affected by this condition,” commented a specialist.
In the absence of effective detection methods for this malignancy, experts emphasized the significance of knowing your family’s cancer history. Some risk factors, such as smoking and excess weight also play a role in the onset of pancreatic cancer.
African Americans have the highest incidence of pancreatic cancer in the U.S. and are most likely to be diagnosed with untreatable disease.
“The initial action toward lowering one’s risk of pancreatic cancer is understanding personal risk factors. Individuals should examine their family history, genetic background, and health issues, such as diabetes, chronic pancreatitis, or obesity that may raise their vulnerability,” advised a medical professional.
Hereditary risk factors are linked to as much as 10% of all pancreatic cancer instances. If a relative in your family has had pancreatic cancer, you may want to consider genetic testing.
“For people with a relative’s background of pancreatic cancer or those having high risk DNA changes, checking may involve advanced imaging such as magnetic resonance imaging (MRI) or internal ultrasound to detect early changes in the pancreas,” he explained.
For those wishing to reduce their risk, lifestyle changes may make a difference. The best step you can take to lower your risk of pancreatic cancer is to stop tobacco use, and if you don’t smoke, avoid exposure altogether.
Excessive alcohol consumption is associated with pancreatitis, a contributing element for pancreatic cancer, so limiting or abstaining from drinks may assist reduce your risk.
Controlling your weight or losing weight may also aid decrease your susceptibility. People with excess weight are 20% more likely to get pancreatic cancer. Pancreatic cancer also occurs more often in people with blood sugar issues, and weight loss can also reduce the chance of type 2 diabetes.
Despite pancreatic cancer’s poor prognosis, there is still hope.
“We are doing better with treatments and newer combination chemotherapy. There are emerging targeted therapies that already are making an impact,” said a expert.
For numerous people, however, education about this uncommon but {dev
A tech enthusiast and software developer with over 10 years of experience specializing in Windows systems and performance tuning.